Despina Komninou, Ph.D. - Publications

Affiliations: 
2000 New York Medical College, New York, NY, United States 
Area:
Pathology

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Komninou D, Malloy VL, Zimmerman JA, Sinha R, Richie JP. Methionine restriction delays aging-related urogenital diseases in male Fischer 344 rats. Geroscience. PMID 31728897 DOI: 10.1007/s11357-019-00129-4  0.537
2016 Bartels LE, Mattheolabakis G, Vaeth BM, LaComb JF, Wang R, Zhi J, Komninou D, Rigas B, Mackenzie GG. The novel agent phospho-glycerol-ibuprofen-amide (MDC-330) inhibits glioblastoma growth in mice: an effect mediated by cyclin D1. Carcinogenesis. PMID 26905586 DOI: 10.1093/Carcin/Bgw017  0.315
2011 Huang L, Mackenzie GG, Sun Y, Ouyang N, Xie G, Vrankova K, Komninou D, Rigas B. Chemotherapeutic properties of phospho-nonsteroidal anti-inflammatory drugs, a new class of anticancer compounds. Cancer Research. 71: 7617-27. PMID 22025561 DOI: 10.1158/0008-5472.Can-11-2349  0.32
2011 Mackenzie GG, Ouyang N, Xie G, Vrankova K, Huang L, Sun Y, Komninou D, Kopelovich L, Rigas B. Phospho-sulindac (OXT-328) combined with difluoromethylornithine prevents colon cancer in mice. Cancer Prevention Research (Philadelphia, Pa.). 4: 1052-60. PMID 21464038 DOI: 10.1158/1940-6207.Capr-11-0067  0.366
2011 Xie G, Sun Y, Nie T, Mackenzie GG, Huang L, Kopelovich L, Komninou D, Rigas B. Phospho-ibuprofen (MDC-917) is a novel agent against colon cancer: efficacy, metabolism, and pharmacokinetics in mouse models. The Journal of Pharmacology and Experimental Therapeutics. 337: 876-86. PMID 21422165 DOI: 10.1124/Jpet.111.180224  0.346
2010 Huang L, Zhu C, Sun Y, Xie G, Mackenzie GG, Qiao G, Komninou D, Rigas B. Phospho-sulindac (OXT-922) inhibits the growth of human colon cancer cell lines: a redox/polyamine-dependent effect. Carcinogenesis. 31: 1982-90. PMID 20627873 DOI: 10.1093/Carcin/Bgq149  0.341
2010 Mackenzie GG, Sun Y, Huang L, Xie G, Ouyang N, Gupta RC, Johnson F, Komninou D, Kopelovich L, Rigas B. Phospho-sulindac (OXT-328), a novel sulindac derivative, is safe and effective in colon cancer prevention in mice. Gastroenterology. 139: 1320-32. PMID 20600034 DOI: 10.1053/J.Gastro.2010.06.044  0.335
2007 Richie JP, Komninou D, Albino AP. Induction of colon tumorigenesis by glutathione depletion in p53-knock-out mice. International Journal of Oncology. 30: 1539-43. PMID 17487376 DOI: 10.3892/Ijo.30.6.1539  0.541
2007 Huang Z, Komninou D, Kleinman W, Pinto JT, Gilhooly EM, Calcagnotto A, Richie JP. Enhanced levels of glutathione and protein glutathiolation in rat tongue epithelium during 4-NQO-induced carcinogenesis. International Journal of Cancer. 120: 1396-401. PMID 17205525 DOI: 10.1002/Ijc.22525  0.601
2006 Komninou D, Leutzinger Y, Reddy BS, Richie JP. Methionine restriction inhibits colon carcinogenesis. Nutrition and Cancer. 54: 202-8. PMID 16898864 DOI: 10.1207/S15327914Nc5402_6  0.587
2005 Chung FL, Komninou D, Zhang L, Nath R, Pan J, Amin S, Richie J. Glutathione depletion enhances the formation of endogenous cyclic DNA adducts derived from t-4-hydroxy-2-nonenal in rat liver. Chemical Research in Toxicology. 18: 24-7. PMID 15651845 DOI: 10.1021/Tx049728+  0.56
2004 Richie JP, Komninou D, Leutzinger Y, Kleinman W, Orentreich N, Malloy V, Zimmerman JA. Tissue glutathione and cysteine levels in methionine-restricted rats. Nutrition (Burbank, Los Angeles County, Calif.). 20: 800-5. PMID 15325691 DOI: 10.1016/J.Nut.2004.05.009  0.582
2003 Komninou D, Ayonote A, Richie JP, Rigas B. Insulin resistance and its contribution to colon carcinogenesis. Experimental Biology and Medicine (Maywood, N.J.). 228: 396-405. PMID 12671184 DOI: 10.1177/153537020322800410  0.488
2003 Kleinman WA, Komninou D, Leutzinger Y, Colosimo S, Cox J, Lang CA, Richie JP. Protein glutathiolation in human blood. Biochemical Pharmacology. 65: 741-6. PMID 12628487 DOI: 10.1016/S0006-2952(02)01560-5  0.5
2002 El-Bayoumy K, Richie JP, Boyiri T, Komninou D, Prokopczyk B, Trushin N, Kleinman W, Cox J, Pittman B, Colosimo S. Influence of selenium-enriched yeast supplementation on biomarkers of oxidative damage and hormone status in healthy adult males: a clinical pilot study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 11: 1459-65. PMID 12433727  0.517
Show low-probability matches.